The tweet was deleted by the author.
But we saved everything 🙂.
Biomea Fusion signals concerns about the risk of beta cell overwork in diabetes. Beta cells, responsible for insulin production, can become overworked over time, leading to reduced insulin production and a progressive loss of glucose control.
This insight sheds light on the intricacies of diabetes development and emphasizes the importance of understanding cellular overwork in the disease's progression. The tweet is part of ongoing discourse regarding potential interventions to maintain insulin production capabilities.
Amid growing scrutiny of beta cell function in diabetes, the discussion aligns with broader considerations about Biomea Fusion’s strategic direction, notably as the company anticipates a year of significant milestones and momentum in 2026, signaling ongoing investment in innovative therapies for metabolic disorders.